Macquarie Group »

Fulcrum Therapeutics shares owned by Macquarie Group

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Macquarie Group from 13F filings

Historical chart of Macquarie Group investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Macquarie Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Macquarie Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 2.5k 9.20
2024-03-31 $41 4.4k 0.01

More positions owned by Macquarie Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Ishares Tr Mortge Rel Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Howmet Aerospace (HWM)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Macquarie Group

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics